| Time | Session |
|---|---|
|
14:00
14:15
|
Evolving clinical trial endpoints: The place of hierarchical endpoints
|
|
14:15
14:30
|
Platform tries in kidney disease-Are we any further ahead?
|
|
14:30
14:45
|
How do we improve participation of underserved populations in clinical trials?
|
|
14:45
15:00
|
Where are we with measuring patient reported outcomes in trials in kidney disease?
|
|
15:00
15:15
|
Evolving with success and working with regulators: Redesigning clinical trials in IgAN trials
|
|
15:15
15:30
|
Q&A
|